Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ASTRAZENECA PHARMA ALEMBIC PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 41.6 88.9 46.8% View Chart
P/BV x 2.2 16.1 14.0% View Chart
Dividend Yield % 1.7 0.3 547.0%  

Financials

 ALEMBIC PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
ASTRAZENECA PHARMA
Mar-22
ALEMBIC PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0904,580 23.8%   
Low Rs6722,529 26.6%   
Sales per share (Unadj.) Rs269.9322.2 83.8%  
Earnings per share (Unadj.) Rs26.224.6 106.5%  
Cash flow per share (Unadj.) Rs40.831.4 129.9%  
Dividends per share (Unadj.) Rs10.0010.00 100.0%  
Avg Dividend yield %1.10.3 403.5%  
Book value per share (Unadj.) Rs266.5203.8 130.8%  
Shares outstanding (eoy) m196.5625.00 786.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.311.0 29.6%   
Avg P/E ratio x33.6144.3 23.3%  
P/CF ratio (eoy) x21.6113.1 19.1%  
Price / Book Value ratio x3.317.4 19.0%  
Dividend payout %38.140.6 93.9%   
Avg Mkt Cap Rs m173,17288,863 194.9%   
No. of employees `000NANA-   
Total wages/salary Rs m11,3302,302 492.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,0588,056 658.6%  
Other income Rs m505148 342.1%   
Total revenues Rs m53,5638,204 652.9%   
Gross profit Rs m8,741862 1,014.3%  
Depreciation Rs m2,868170 1,691.9%   
Interest Rs m17710 1,866.3%   
Profit before tax Rs m6,201830 746.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,045214 487.2%   
Profit after tax Rs m5,157616 837.1%  
Gross profit margin %16.510.7 154.0%  
Effective tax rate %16.825.8 65.2%   
Net profit margin %9.77.6 127.1%  
BALANCE SHEET DATA
Current assets Rs m29,7487,653 388.7%   
Current liabilities Rs m18,3063,923 466.6%   
Net working cap to sales %21.646.3 46.6%  
Current ratio x1.62.0 83.3%  
Inventory Days Days1161 17.2%  
Debtors Days Days639 14.3%  
Net fixed assets Rs m42,5542,120 2,007.2%   
Share capital Rs m39350 786.2%   
"Free" reserves Rs m51,9825,044 1,030.5%   
Net worth Rs m52,3755,094 1,028.1%   
Long term debt Rs m00-   
Total assets Rs m72,3029,773 739.8%  
Interest coverage x36.088.4 40.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 89.0%   
Return on assets %7.46.4 115.3%  
Return on equity %9.812.1 81.4%  
Return on capital %12.216.5 73.9%  
Exports to sales %43.80-   
Imports to sales %12.731.7 40.0%   
Exports (fob) Rs m23,251NA-   
Imports (cif) Rs m6,7282,552 263.6%   
Fx inflow Rs m23,251442 5,260.4%   
Fx outflow Rs m6,7282,552 263.6%   
Net fx Rs m16,523-2,110 -783.1%   
CASH FLOW
From Operations Rs m5,5241,008 548.0%  
From Investments Rs m-3,72047 -7,847.3%  
From Financial Activity Rs m-2,174-95 2,297.6%  
Net Cashflow Rs m-370961 -38.5%  

Share Holding

Indian Promoters % 69.1 0.0 -  
Foreign collaborators % 0.5 75.0 0.7%  
Indian inst/Mut Fund % 17.9 3.8 469.0%  
FIIs % 5.3 2.5 213.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 25.0 121.6%  
Shareholders   103,811 49,085 211.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on ALEMBIC PHARMA vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs ASTRAZENECA PHARMA Share Price Performance

Period ALEMBIC PHARMA ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 0.87% -1.56% -0.10%
1-Month -2.19% -3.79% -1.99%
1-Year -25.46% 5.50% -5.62%
3-Year CAGR 2.57% 5.18% 20.96%
5-Year CAGR 3.16% 24.13% 11.47%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

ASTRAZENECA PHARMA paid Rs 10.0, and its dividend payout ratio stood at 40.6%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.